Switching the basal insulin to insulin glargine 300 U/ ml in people with type 2 diabetes under basal insulin supported oral therapy: Observational trial on effectiveness and safety-Reference-Cited by-同舟云学术

Switching the basal insulin to insulin glargine 300 U/ ml in people with type 2 diabetes under basal insulin supported oral therapy: Observational trial on effectiveness and safety

Published:2021-09-24 Issue:1 Volume:24 Page:72-81
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Seufert Jochen¹^ORCID,Wiesli Peter²^ORCID,Fritsche Andreas³⁴^ORCID,Anderten Helmut⁵,Pegelow Katrin⁶^ORCID,Pscherer Stefan⁷,Pfohl Martin⁸^ORCID

Affiliation:

1. Division of Endocrinology and Diabetology, Department of Medicine II, Medical Center, University of Freiburg, Faculty of Medicine University of Freiburg Freiburg Germany

2. Hospital for Internal Medicine Kantonsspital Frauenfeld Frauenfeld Switzerland

3. Hospital for Internal Medicine IV University of Tuebingen Tuebingen Germany

4. Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich University of Tuebingen (IDM) Tuebingen Germany

5. Joint Practice Anderten‐Krok & Partner Hildesheim Germany

6. Sanofi‐Aventis Deutschland GmbH Berlin Germany

7. Department of Internal Medicine III Sophien‐ and Hufeland‐Hospital Weimar Germany

8. Medical Clinic I Evang. Bethesda‐Hospital Duisburg Duisburg Germany

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14549

Reference30 articles.

1. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

2. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

3. Praxisempfehlungen der Deutschen Diabetes Gesellschaft. Therapie des Typ‐2‐Diabetes;Landgraf R;Diabetologie,2020

4. LehmannR GastaldiG CzockA EgliM Fischer‐TaeschlerD LaimerM LucchiniB ThalmannS WiesliP.Empfehlungen der Schweizerischen Gesellschaft für Endokrinologie und Diabetologie (SGED/SSED) für die Behandlung von Diabetes mellitus Typ 2 (2020) 28 February 2020. .https://www.sgedssed.ch/fileadmin/user_upload/6_Diabetologie/61_Empfehlungen_Facharzt/2020_Swiss_Recomm_Medis_DE_def.pdf

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Evidence and Practice-Based Guidelines on the Utility of Basal Insulin Combined Oral Therapy (Metformin and Glimepiride) in the Current Era;Current Diabetes Reviews;2023-10

2. Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database;Diabetes Therapy;2023-01-04

3. Trends in basal insulin prescribing in older adults with chronic kidney disease in Ontario, Canada: A population‐based analysis from 2010 to 2020;Diabetes, Obesity and Metabolism;2022-01-11